Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T55285 | ||||
Target Name | Glycine receptor (GlyR) | ||||
Type of Target |
Successful |
||||
Drug Potency against Target | (12E,20Z,18S)-8-hydroxyvariabilin | Drug Info | IC50 = 7000 nM | [3] | |
10-methoxy-ginkgolide C | Drug Info | IC50 = 7800 nM | [2] | ||
3,14-DIDEHYDROGINKGOLIDE A | Drug Info | IC50 = 9500 nM | [2] | ||
3-demethoxy-3-D-lyxopyranosylaminothiocolchicine | Drug Info | IC50 = 4100 nM | [1] | ||
3-demethoxy-3-D-mannopyranosylaminothiocolchicine | Drug Info | IC50 = 13100 nM | [1] | ||
3-demethoxy-3-D-xylopyranosylaminothiocolchicine | Drug Info | IC50 = 3300 nM | [1] | ||
3-demethoxy-3-L-fucopyranosylaminothiocolchicine | Drug Info | IC50 = 4200 nM | [1] | ||
3-demethoxy-3D-glucopyranosylaminothiocolchicine | Drug Info | IC50 = 10600 nM | [1] | ||
GINKGOLIDE A | Drug Info | IC50 = 2100 nM | [2] | ||
Ginkgolide C | Drug Info | IC50 = 8200 nM | [2] | ||
Ginkgolide J | Drug Info | IC50 = 12000 nM | [2] | ||
Ginkgolide M | Drug Info | IC50 = 1300 nM | [2] | ||
GINKOLIDE B | Drug Info | IC50 = 3700 nM | [2] | ||
THIOCOLCHICOSIDE | Drug Info | IC50 = 1500 nM | [1] | ||
[3H]strychnine | Drug Info | IC50 = 14 nM | [1] | ||
Action against Disease Model | GW 468816 | Drug Info | The effect of bicuculline on the inhibition of the spontaneous firing of two Purkinje cells(A, B) by GABA (solid line, 5 nA). | [4] | |
References | |||||
REF 1 | 3-demethoxy-3-glycosylaminothiocolchicines: Synthesis of a new class of putative muscle relaxant compounds. J Med Chem. 2006 Sep 7;49(18):5571-7. | ||||
REF 2 | Probing the pharmacophore of ginkgolides as glycine receptor antagonists. J Med Chem. 2007 Apr 5;50(7):1610-7. | ||||
REF 3 | Ircinialactams: subunit-selective glycine receptor modulators from Australian sponges of the family Irciniidae. Bioorg Med Chem. 2010 Apr 15;18(8):2912-9. | ||||
REF 4 | Antagonism between bicuculline and GABA in the cat brain. Brain Res. 1971 Oct 8;33(1):57-73. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.